Search results
Results from the WOW.Com Content Network
diabetes mellitus, Dermatomyositis: DM2: Type 2 diabetes, formerly known as Non-Insulin Dependent Diabetes Mellitus (NIDDM). DMARD: disease-modifying antirheumatic drug: DMD: Duchenne muscular dystrophy; Dentariae Medicinae Doctor, that is, Doctor of Dental Medicine: DME: durable medical equipment: DMPA: depot medroxyprogesterone acetate: DMSA ...
Acronyms Diseases and disorders JAS Juvenile ankylosing spondylitis: JBS Johanson–Blizzard syndrome: JE Japanese encephalitis: JHD Juvenile Huntington's disease: JMML Juvenile myelomonocytic leukemia: JODM Juvenile onset diabetes mellitus: JPA Juvenile pilocytic astrocytoma: JRA Juvenile rheumatoid arthritis: JWS Jackson–Weiss syndrome
Insulin-dependent diabetes mellitus (IDDM) An out-of-date term for Type 1 diabetes mellitus. See: Type 1 diabetes mellitus. Insulin-induced atrophy Small dents that form on the skin when a person keeps injecting a needle in the same spot. They are harmless. See also: Lipoatrophy; injection site rotation. Insulin-induced hypertrophy
adult-onset diabetes mellitus (now called diabetes mellitus type 2) AOM: acute otitis media: AOE: acute otitis externa: a.p. before a meal (from Latin ante prandium) AP: action potential alkaline phosphatase angina pectoris anteroposterior apical area postrema: A&P: auscultation and percussion anatomy and physiology: A/P: anatomy and physiology ...
Warfarin is indicated for the prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism; [9] prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement; [9] and reduction in the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after ...
Diabetes mellitus (DM) is a type of metabolic disease characterized by hyperglycemia. It is caused by either defected insulin secretion or damaged biological function, or both. The high-level blood glucose for a long time will lead to dysfunction of a variety of tissues.
The only approved use of the thiazolidinediones is in diabetes mellitus type 2. According to a 2014 Cochrane systematic review of four randomized controlled trials , PPARγ-agonists may be effective in preventing further strokes in those who have already had a stroke or a transient ischemic attack (TIA) and may stabilize atherosclerotic plaques ...
The European Society of Cardiology (ESC), [21] and National Institute for Health and Care Excellence (NICE) [23] guidelines recommend that if the patient has a CHA 2 DS 2-VASc score of 2 and above, oral anticoagulation therapy (OAC) with a vitamin K antagonist (VKA, e.g. warfarin with target INR of 2-3) or one of the direct oral anticoagulant ...